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Lineage-tracing approaches, widely used to charac-
terize stem cell populations, rely on the specificity
and stability of individual markers for accurate
results. We present a method in which genetic
labeling in the intestinal epithelium is acquired as a
mutation-induced clonal mark during DNA replica-
tion. By determining the rate of mutation in vivo and
combining this data with the known neutral-drift
dynamics that describe intestinal stem cell replace-
ment, we quantify the number of functional stem cells
in crypts and adenomas. Contrary to previous
reports, we find that significantly lower numbers of
‘‘working’’ stem cells are present in the intestinal
epithelium (five to seven per crypt) and in adenomas
(nine per gland), and that those stem cells are also
replaced at a significantly lower rate. These findings
suggest that the bulk of tumor stem cell divisions
serve only to replace stem cell loss, with rare clonal
victors driving gland repopulation and tumor growth.
INTRODUCTION
Adult stem cells in the intestinal epithelium, as in other tissues,
were originally defined by clonogenic assays in which they
demonstrated a sustained ability to generate cellular progeny
(Siminovitch et al., 1963; Till and McCulloch, 1961; Winton
et al., 1988). More recently, endogenous molecular markers
have been associated with different subpopulations of intestinal
stem cells that demonstrate clonogenicity in genetic-marking
experiments, creating much debate about which populations
lie ancestrally upstream of others (Barker et al., 2007; Mon-
tgomery et al., 2011; Sangiorgi and Capecchi, 2008).
Recent studies have identified significant amounts of overlap
of transcriptional and protein profiles in two clonogenic popula-
tions in the intestine: the crypt base and suprabasal stem cells,
as defined by Lgr5 and Hopx/Bmi1 expression, respectively
(Itzkovitz et al., 2012; Mun˜oz et al., 2012). It has also been shown
that a bidirectional relationship exists between cells at these626 Cell Stem Cell 13, 626–633, November 7, 2013 ª2013 Elsevier Inlocations, suggesting that markers may be inaccurate in identi-
fying the size of the stem cell pool, as they may be lost or others
acquired (Takeda et al., 2011). Thus, that all cells defined by
marker expression are required for actively maintaining the
tissue remains an assumption that has not yet been tested. An
alternative possibility is that there is redundancy such that only
a proportion of cells sharing a common potentiality actually
achieve it.
Similarly, the bulk of evidence for cancer stem cells (CSCs)
comes from cell-surface markers that enrich for tumor regrowth
on xenotransplantation of disaggregated tumor cells in immuno-
compromised mice (Shackleton et al., 2009). Such assays may
not accurately reflect the native clonogenicity of tumor cells
in situ. Moreover, the validity and robustness of CSC markers
have been cause for debate (O’Brien et al., 2007; Shmelkov
et al., 2008). An alternative and recent approach to validating
the CSC concept in mice has been to lineage trace the progeny
derived from known stem cell markers such as Lgr5 using intra-
tumoral Cre-mediated recombination (Schepers et al., 2012).
This single study in intestinal adenomas has shown that, within
a large population of Lgr5+ stem cells, some are clonogenic,
and other populations remain untested. Therefore, the size of
the clonogenic population acting to maintain the tumor is
unknown.
Here, we apply a functional approach independent of stem
cell-specific markers. Based on the principle of continuous
clonal labeling, it allows the dynamics of clonogenic stem cell
replacement to be quantified. This approach exploits the relative
instability of dinucleotide repeat tracts during DNA replication by
placing a [CA]30 tract within a reporter gene. Expression of the
reporter gene is only obtained following frameshift mutation.
Microsatellite repeats have been used previously to estimate
the mitotic age of various tissues in the mouse and have demon-
strated the known monoclonality of intestinal crypts; however,
the intracrypt dynamics of stem cell replacement have not
been addressed using this technique (Reizel et al., 2011). Clonal
analysis of human tumors has been restricted to comparing the
relatedness of different tumor areas based on changes in
methylation patterns (Humphries et al., 2013).
Through analyzing the fate of clones arising during continuous
labeling, smaller numbers of stem cells with lower rates of
replacement are found to maintain intestinal crypts than hasc.
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Subsequent application to intestinal adenomas similarly shows
them to be maintained by an unexpectedly small (less
than 1%) population characterized by an accelerated rate of
stem cell replacement. These results show that adenoma stem
cell divisions are inefficient in driving tumor growth and, rather,
act to maintain tumor mass via cell turnover.
RESULTS
Formation andAnalysis of ClonesArising viaContinuous
Labeling
To allow ongoing genesis of clones, we placed an out-of-frame
SYNbglA reporter gene in the Rosa26 housekeeping locus.
Expression arose following replication slippage of a [CA]30 dinu-
cleotide repeat placed between the translational start site and
the remaining coding sequence (Figure 1A). Clones visualized
in whole-mount preparations of adult R26[CA]30SYNbglA animals
were easily recognized in two ways: first, by migration streams
arising from stained crypts and ascending neighboring villi in
the small intestine (SI) (Figure 1B); second, as partly or wholly
populated crypts in both the SI and colon (Figures 1C and 1D).
These clonal patterns are identical to those observed following
Cre-mediated ‘‘pulse-chase’’ clone induction and correspond
to transition and fixed clonal forms, respectively (Lopez-Garcia
et al., 2010; Snippert et al., 2010; Winton and Ponder, 1990).
Adult R26[CA]30SYNbglA mice were aged, and the frequency of
wholly and partly populated crypts was determined at three
intestinal regions, namely proximal SI, distal SI, and colon. This
revealed a linear age-related accumulation of wholly populated
crypts up to 759 days (Figures 1E–1G). Notably, the rate of accu-
mulation per 105 crypts was higher in the distal SI and colon
(2.7 ± 0.5 and 2.8 ± 0.4 per day, respectively) than in the proximal
SI (1.0 ± 0.1 per day) (95% confidence interval [CI]). The partly
populated, transition-form crypts remain at a constant frequency
throughout life but at a level that varied between the different
intestinal regions scored (Figures 1E–1G). There are, on average,
132 ± 6, 190 ± 28, and 229 ± 27 (95%CI) partly populated crypts
per 105 crypts in the proximal SI, distal SI, and colon, respec-
tively. These observations demonstrate that there are regional
differences in the rates of clone formation and in the conversion
of crypts to monoclonality.
Application of Neutral-Drift Theory
to Continuous-Labeling Data
The random process of neutral drift, whereby transition-form
crypts resolve to monoclonality, is known to arise from a mode
of symmetric stem cell replacement that allows clones to expand
and contract as stem cell loss is compensated by the prolifera-
tion of neighbors (Lopez-Garcia et al., 2010; Snippert et al.,
2010). Notably, we observed that the numbers of partly popu-
lated crypts remain unchanged with age, whereas wholly popu-
lated crypts accumulate at a predictable rate in R26[CA]30SYNbglA
mice. This indicates that the de novo appearance of partly popu-
lated crypts is balanced either by loss of labeled clones or their
expansion to populate whole crypts. Such behavior is predicted
by neutral-drift theory.
A mathematical model was developed that accounts for the
continuous appearance of newly labeled cells, as well as theCellsubsequent neutral-drift dynamics that follow labeling (Supple-
mental Experimental Procedures available online). The model
accurately predicts that the rate of accumulation of wholly
populated crypts ðDCfixÞ is linear and that the frequency of tran-
sition-form clones, or partly populated crypts ðCpartÞ, remains
constant over time. The former depends on two variables: the
mutation rate of the [CA]30 tract and the rate of stem cell replace-
ment per crypt ðlcryptÞ. The latter depends on mutation rate and
the number of stem cells per crypt ðNcryptÞ. Thus, both parame-
ters share a common dependency on mutation rate. The clone
incidence data in Figures 1E–1G shows a constant relationship
between fixed and transition forms, demonstrating that both
the number of stem cells and their rate of replacement do not
change with age.
Determining the [CA]30 Mutation Rate
Specific values for stem cell number and replacement rate can
be inferred by calculating the mutation rate of the [CA]30 dinucle-
otide repeat (a). R26[CA]30EYFP animals with an EYFP reporter
gene were generated and used to determine the intestinal
[CA]30 mutation rate (Supplemental Experimental Procedures
and Figure S1A). Crypts transected immediately above the crypt
base were scored for the presence of single or pairs of EYFP+
cells (Figure 1H). Adjacent serial sections were then scored to
ensure that these positive cells were not part of a larger,
pre-existing clone and were therefore de novo mutations. This
analysis identified 34 positive cells in 17,000 crypts scored
(equating to 289,000 cells scored), allowing the in vivo rate of
mutagenesis of the [CA]30 tract to be calculated as 1.17 3
104 ± 0.40 3 104 (95% CI) mutants per mitosis (Figure 1I
and Supplemental Experimental Procedures).
In addition, the mutation rate was estimated in mouse embry-
onic fibroblast (MEF) cultures derived from R26[CA]30EYFP mice
and found to be 1.06 3 104 ± 0.38 3 104 (95% CI) mutants
per mitosis (Figures 1I and S1B–S1D). Published estimates for
mutation rates of similarly sized repeat tracts are consistent
with those described here (Yamada et al., 2002). Cumulatively,
these observations suggest that the mutation rate for a given
repeat tract, in mismatch-repair-competent cells, does not
vary between highly different cellular contexts.
Determining Stem Cell Number and Replacement Rate
Themutation rate was then used together with the equations that
describe DCfix andCpart for calculating both lcrypt andNcrypt. This
analysis indicates that there are 5 ± 0.3, 6 ± 0.4, and 7 ± 0.3 (95%
CI) stem cells per crypt in proximal SI, distal SI, and colon,
respectively, and that the rate at which an individual stem cell
is replaced per day is 0.1 ± 0.01, 0.2 ± 0.05, and 0.3 ± 0.04
(95% CI), respectively. The resulting fit overlays with the data
for each region, whereas higher values for number and replace-
ment rate do not (Figures 1E–1G and 1J). Thus, regional differ-
ences in the dynamics of neutral drift arise from differences in
both the number of stem cells per crypt and the rate at which
they are replaced.
Reconciliation with Pulse-Chase Analyses
Strikingly, these estimates suggest both lower numbers of stem
cells per crypt and rates of stem cell replacement compared
to those derived using pulse-chase labeling (16 stem cells;Stem Cell 13, 626–633, November 7, 2013 ª2013 Elsevier Inc. 627
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Figure 1. Clone Data Acquired Using the R26[CA]30 Continuous-Labeling Strategy
(A) R26[CA]30mice contain a [CA]30 dinucleotide repeat and a reporter gene, either SYNbglA or EYFP, targeted to the Rosa26 locus. When the repeat tract is intact
([CA]30) the reporter gene is out of frame. If strand slippage occurs during DNA replication, the insertion of one CA will push the reporter gene in-frame, leading to
translation of a fully functional protein.
(B) Representative image of a fully labeled crypt in the distal SI, lightly counterstained with Alcian blue (scale bar represents 25 mm).
(C and D) Representative images of whole-mounted tissue showing partly (C) or wholly (D) populated crypts in the proximal SI. Crypts are denoted with a ‘‘c,’’ a
dashed line indicates the labeled crypt boundary, and dotted lines encircle villi (v) out of the focal plane. Scale bars represent 25 mm.
(E–G) Scatter plots showing the number of partly populated crypts (PPC) and wholly populated crypts (WPC) in the proximal SI (E), distal SI (F), and colon (G). In all
three regions the number of partly populated crypts remains stable with age, whereas the number of wholly populated crypts increases linearly with age. The
age-related behavior of wholly populated and partly populated crypts as predicted by neutral drift overlays with the data observed in vivo in the proximal SI (E),
distal SI (F), and colon (G). The orange lines indicate the theoretical prediction of the data when a = 1.1 3 104.
(H) EYFP immunohistochemistry in en face sections of SI tissue taken fromR26[CA]30EYFPmice and showing a crypt containing a single positive cell next to a wholly
stained crypt. The inset shows an enlargement of the area (scale bars represent 50 mm).
(I) Graph showing themutation rate of the [CA]30 tract obtained in vivo from en face sections ofR26
[CA]30EYFP SI tissue and in vitro fromR26[CA]30EYFP-derivedMEF
cultures. Data are presented with 95% CI.
(J) Theoretical predictions of the per-mouse average number of PPC versusWPC for a range of values of Ncrypt and lcrypt. Possible values of Ncrypt are represented
by circles of increasing size, whereas possible values of lcrypt are represented by orange lines. The three crosses represent the data averaged over the full data set
for proximal SI (blue), distal SI (red), and colon (green).
See also Figures S1 and S2.
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Continuous Clonal Labeling and Stem Cell Dynamicsreplacement rate of 0.74–1 per stem cell per day), which
assumed that the number of stem cells per crypt corresponds
to the total number of crypt-base intercalated or Lgr5+ cells
(Lopez-Garcia et al., 2010; Snippert et al., 2010). To explain
this disparity, we sought to identify the optimal values for the628 Cell Stem Cell 13, 626–633, November 7, 2013 ª2013 Elsevier Innumber and replacement rate of stem cells required to generate
the clone size distributions previously observed following induc-
tion pulses in the SI of Lgr5EGFP-IRES-creERT2/R26Confetti mice
and in the colon of AhcreERT/R26SYNbglA mice (Lopez-Garcia
et al., 2010; Snippert et al., 2010). The fit to the data was foundc.
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Figure 2. Growth of Apcmin Adenomas and Predicted R26[CA]30 Clone Data
(A) Longitudinal section showing distribution of Lgr5+ cells in an Apcmin adenoma revealed using immunohistochemistry to EGFP (scale bar represents 50 mm).
(B) Longitudinal section showing distribution of Lgr5+ cells in an Apcmin adenoma and neighboring normal crypt revealed using immunofluorescence to EGFP
(scale bar represents 100 mm).
(C) Quantification of the number of adenomas per whole mount (p < 2 3 1015).
(D) Quantification of the size of the five largest adenomas per whole mount (p < 2 3 1016).
(E) Representative image of two adenomas (Ad) from an R26[CA]30SYNbglA/Apcmin whole mount with individual large SYNbglA-positive clones clearly visible.
(F and G) Adenomas isolated from R26[CA]30SYNbglA/Apcmin mice contain clones as seen en face (F) or on edge (G) in 20 mm vibratome sections (scale bar
represents 250 mm).
(H) Frequency histogram of clone incidence per adenoma.
(legend continued on next page)
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squared error) using values derived from continuous clonal
labeling of six stem cells per crypt and a replacement rate of
0.2 stem cells per day in the distal SI and seven stem cells per
crypt and a replacement rate of 0.3 stem cells per day in the
colon, compared to those originally proposed (Figures S2A
and S2C and Supplemental Experimental Procedures).
Recently it has been suggested that high doses of tamoxifen
may ablate stem cells and cause a regenerative response in the
intestinal epithelium (Zhu et al., 2013). To test for an effect of
tamoxifen dose, we performed a similar analysis using the induc-
ible cre lines AhcreERT/R26tdTomato and Lgr5EGFP-IRES-creERT2/
R26tdTomato at greatly reduced doses of tamoxifen (0.15 mg
versus the 5 mg used previously). In both cases, the resultant
changes in clone-size distribution are best explained by the
values for stem cell number and replacement rate derived from
continuous labeling (Figures S2B and S2D and Supplemental
Experimental Procedures). Taken together, these data indicate
that the estimates of lcrypt and Ncrypt obtained using continuous
clonal labeling are in concordance with pulse-chase data, and
that clone-size distributions are not influenced by tamoxifen
dose, making it unlikely that tamoxifen ablates functional stem
cells.
Predictions of Neutral-Drift Theory in Apcmin Adenomas
Analysis by ‘‘retracing’’ in adenomas previously described in
qualitative terms that individual Lgr5+ stem cells rapidly populate
adenomatous glands (Schepers et al., 2012). However, with
potentially hundreds of stem cells per gland identifiable by this
criterion, the actual number of clonogenic cells remains un-
known. The cellular content of transformed glands from ten
Lgr5EGFP-IRES-creERT2/Apcmin tumors was estimated from
longitudinal histological sections at 1,906 cells ± 396 (95% CI).
Individual tumors were analyzed for EGFP+ cells using immuno-
fluorescence and immunohistochemistry. Immunoreactivity was
extensive and extended from the base to the upper half of
glands, suggesting that the Lgr5+ population must be on the
order of several hundred per gland (Figures 2A and 2B). This
finding was confirmed by quantification of Lgr5hi-expressing
cells in Lgr5EGFP-IREScreERT2/R26tdTomato/Apclx/lx mice following
Apc deletion that indicated that around 20%of cells in an adeno-
matous gland (equating to400 cells) express Lgr5 (Figures S3A
and S3B). This motivated us to consider applying continuous
labeling to determine stem cell numbers and rates of replace-
ment following neoplastic transformation.
In Apcmin mice, intestinal adenoma development proceeds
during adult life because of an inactivating germline mutation
of Apc. Cohorts of R26[CA]30SYNbglA/Apcmin mice were aged,
and animals were killed for clone detection between 41 and
200 days of age. Visual inspection confirmed the presence of
adenomas. A computational analysis of digitized images of
whole mounts was undertaken using a custom-built automated
algorithm for adenoma (and subsequent clone) recognition (Fig-
ure S3C and Supplemental Experimental Procedures). The(I) Quantification of the observed clone-size distribution within adenomas. The re
(J–L) Representative images of EYFP+ clones within adenomas taken from R26[C
adenoma (Ad) is visible next to adjacent normal (Norm) tissue. In (K) a large clon
See also Figure S3.
630 Cell Stem Cell 13, 626–633, November 7, 2013 ª2013 Elsevier Inanalysis identified 411 adenomas in 11 animals and confirmed
that both adenoma number and size increase with age (Figures
2C and 2D). To accurately quantify the growth of adenomas,
the five largest adenomas per whole mount were selected as
being the most established and probable to have been present
throughout adult life. Apcmin adenomas are known to grow
through the process of gland fission (Wasan et al., 1998). Using
the average gland size and the size of each adenoma, we were
able to calculate an adenoma growth rate of approximately six
glands per day (Figures S3D–S3F). This growth rate was then
used to determine the estimated age (in days) of each adenoma
analyzed.
Clonal Patterns in R26[CA]30SYNbglA/Apcmin Adenomas
Visual inspection of R26[CA]30SYNbglA/Apcmin whole mounts
confirmed that a substantial proportion of adenomas contained
contiguous clones. Importantly, clones occupied only a
proportion of the adenoma mass, indicating that the [CA]30
mutations had occurred within the developing tumor (Figure 2E).
A proportion of clone-bearing adenomas from R26[CA]30SYNbglA/
Apcmin mice were excised and sectioned en face and on edge,
and the staining patterns were analyzed to establish that
glands orientate vertically along the same axis as that of normal
crypts and that clones typically occupy one or more glands (Fig-
ures 2F and 2G). This confirmed that two-dimensional (2D)
area measurements, by capturing the glandular content of
adenomas, accurately quantified the size of clones. The compu-
tational analysis of digitized images of whole mounts from
R26[CA]30SYNbglA/Apcmin mice was extended to include clone
recognition. This analysis established that 222 of 411 adenomas
in 11 animals contained clones (Figure 2H and Supplemental
Experimental Procedures).
Application of Neutral-Drift Theory to R26[CA]30SYNbglA/
Apcmin Adenomas
Notably, the image analysis provides two pieces of information:
clone size and clone incidence. The distribution of observed
clone sizes within an Apcmin adenoma is broad. Of the 474
clones analyzed, over 70% were larger than the average
gland size (Figure 2I). Very small clones were not observed
macroscopically in the whole mounts or microscopically in
histological-tissue sections of the adenomas. A 2D analysis of
EYFP-positive clones from R26[CA]30EYFP/Apcminmice confirmed
the observation of small numbers of large, contiguous clones
(Figures 2J–2L).
We then adapted the mathematical model described above to
predict the clone-size distributions for specific values of the
number of stem cells per adenomatous gland ðNglandÞ and the
rate of stem cell replacement ðlglandÞ (Supplemental Experi-
mental Procedures). When values for Ngland are low (e.g.,
Ngland = 10), the resulting clones are predicted to be rare and
large in size. This is in striking contrast to situations wherein
values for Ngland are high (e.g., Ngland = 50), which, regardless
of the value of lgland, should result in a large number of smalld line denotes the average gland size.
A]30EYFP/Apcmin whole mounts (scale bar represents 100 mm). In (J) a region of
e occupies multiple glands. (L) shows a magnified view.
c.
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Partly populated glands per adenoma
Figure 3. Application of the Continuous
Clonal Label to Apcmin Adenomas
(A) Theoretical predictions of the per-adenoma
average number of partly populated versus wholly
populated glands for a range of values of Ngland
and lgland. Possible values of if Ngland are repre-
sented by circles of increasing size, whereas
possible values of lgland are represented by
orange lines. The black cross represents the data
averaged over all adenomas.
(B) Quantification of the number of individual
clones per R26[CA]30SYNbglA/Apcmin adenoma
plotted against age. Bayesian inference predicts
that Ngland = 9 and lgland = 1 (yellow line). Data are
presented as the mean ± SEM.
(C) Schematic representation of the intratumoral
clonal patterns expected for low (left panel) and
high (right panel) numbers of stem cells. The
former model is supported by the data presented.
See also Figure S3.
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Continuous Clonal Labeling and Stem Cell Dynamicsclones (Figure 3A). These predictions suggest that small
numbers of large clones in adenomas are the result of a small
number of stem cells per gland.
Precise values of Ngland and lgland were calculated using
Bayesian inference from the clone-incidence data (Supple-
mental Experimental Procedures). This model predicts that
Ngland = 9 (99% CI between 8 and 9) and lgland = 1 (99% CI
between 0.85 and 1.17) and provides a good fit to the observed
clone-incidence data (Figure 3B). When the clone-size data for
intratumor clones are considered (as large and small clones,
greater or less than the mean gland size, respectively), the
data are consistent with that predicted for this low value of
Ngland (Figure 3A). These data confirm the hypothesis that clones
observed in adenomas are the result of a small number of stem
cells per gland (Figure 3C).
DISCUSSION
We have described a clonal-labeling approach that allows intes-
tinal stem cells to be retrospectively analyzed over the lifetime of
the organism. Strikingly, continuous clonal labeling demon-
strates that previous inferences of stem numbers and replace-
ment rates derived from pulse-chase labeling are overestimates.
The explanation is surprisingly simple: the dynamics governing
changes in clone size have been wrongly assumed to arise
from the behavior of all cells in a given population rather than
only a subset.
In other stem cell systems, there is evidence of stem cell
exhaustion in aging animals (Chambers et al., 2007; PietrasCell Stem Cell 13, 626–633,et al., 2011). In hematopoiesis, this mani-
fests as an increase in the number of
phenotypic stem cells that are function-
ally impaired in respect to being able to
support multilineage reconstitution on
transplantation and in the number of cell
divisions they can undergo (Rossi et al.,
2005; Janzen et al., 2006; Nygren and
Bryder, 2008). We have shown that both
the number of intestinal stem cells andtheir rate of replacement are unchanging up to at least 2 years
of age, and therefore we find no evidence for the exhaustion of
intestinal stem cells during adult life.
The precise identity of the stem cells maintaining the intestinal
epithelium has been much debated, with alternative views either
supporting the Lgr5+ intercalated cells of the crypt base or the
supra-Paneth cells that express markers such as Hopx. Recent
attempts to resolve this debate have focused on the overlap in
expression between the populations (Itzkovitz et al., 2012;
Mun˜oz et al., 2012). This appears to suggest that Lgr5 expres-
sion defines all putative stem populations and cell locations.
Establishing that only a proportion (30%–50%) of the lower crypt
population act as the de facto stem cells raises the possibility
that such cells may require the expression of other factors in
addition to Lgr5. Alternatively, Lgr5 expression may be sufficient
for stem cell potential, but redundancy within the populationmay
mean that only a proportion actually achieves it.
The consequences of both reduced numbers of stem cells and
the rates of stem cell replacement observed here are profound. It
was previously estimated that a stem cell replaced its neighbor
once every 32 hr, approximating to the 24 hr cell-cycle time of
crypt-base cells (Snippert et al., 2010). Our revised parameters
show this to be once every 5 or 10 days for proximal and distal
SI, respectively, suggesting that there are more divisions than
stem cell replacement events. These additional stem cell divi-
sions probably reflect asymmetric fates for their daughters.
Interpretation of continuous-labeling data requires an estimate
of mutation rate that might be predicted to vary with different
tissue contexts. However, we find that this is not the case byNovember 7, 2013 ª2013 Elsevier Inc. 631
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epithelial cells in vivo, suggesting that other factors such as chro-
matin context may be more relevant than tissue context in deter-
mining the susceptibility of the locus to mutation.
Continuous labeling has the advantage of not requiring an
experimental intervention to induce Cre-mediated recombina-
tion. Recently, it has been proposed that tamoxifen treatment,
common to pulse-chase experiments, effectively ablates cells,
and that some or all of the subsequent inferences are influenced
by regenerative effects (Zhu et al., 2013). Comparison of our own
(low-dose) pulse-chase clone data with that published following
a high-dose protocol identifies no obvious effect over a 30-fold
dosing range. The consistency of our estimates of stem cell
number and rate of replacement using both continuous and
pulse-chase labeling demonstrates that the effect of tamoxifen
toxicity is minimal.
The widespread expression of Lgr5 in adenomas suggests a
potential population of several hundred stem cells in each
adenomatous gland (Schepers et al., 2012). However continuous
clonal labeling identifies much smaller numbers of working stem
cells. Given that vertical cellular migration in adenomas has been
described previously, it appears that most of the Lgr5+ popula-
tion is not part of a stable stem cell zone but rather that they
actively migrate (Wong et al., 2002). Within this arrangement,
only the progeny of stem cells situated toward the base of glands
are retained. Furthermore, unlike homeostasis, the replacement
rate of this small number of stem cells (100% replaced per day)
closely approximates the cell-cycle time, requiring all adenoma
stem cell divisions to be symmetric and leading to replacement
of or by neighbors.
It is implicit in the CSC hypothesis that following oncogenic
transformation a higher proportion of stem cell divisions will be
self-renewing and that this drives adenoma growth. Here, we
show that this process is remarkably inefficient. For example,
in an adenoma comprised of 100 adenomatous glands (with
nine stem cells per gland), of the 900 stem cell-renewal events
per day, around 850 will be to replace existing stem cells and
only 50 will contribute to the growth of the tumor. Thus, the
majority of self-renewing divisions act to replace stem cells
lost from the adenoma presumably due to either commitment
or cell death. The net effect of this organization is that clones
inevitably populate intratumoral territories maintained by a
common stem cell pool. It follows that the bulk of tumor stem
cells are primed for displacement and eventual extinction and
that drugs enhancing this predisposition may form the basis for
novel therapies.EXPERIMENTAL PROCEDURES
Genetically Modified Animals
The R26[CA]30SYNbglA and R26[CA]30EYFP strains have not been previously
described. In brief, [CA30]-SYNBglA and [CA30]-EYFP reporter cassettes
were synthesized by Yorkshire Bioscience. These were subsequently subcl-
oned by Nhe1 digestion into the pROSA-MCS13-puro targeting construct
(Vooijs et al., 2001). Gene targeting was carried out by the transgenic facility
at the Cancer Research UK London Research Institute in an embryonic stem
cell line of C57Bl/6 genetic background (cell line: B6 1.1). R26[CA]30SYNbglA
and R26[CA]30EYFP mice were subsequently maintained as hemizygotes on a
C57Bl/6J genetic background. R26[CA]30SYNbglA and R26[CA]30EYFP mice were
crossed with Apcmin mice (Jackson Laboratory, stock number: 002020).632 Cell Stem Cell 13, 626–633, November 7, 2013 ª2013 Elsevier InAnimals carrying both alleles were selected for further analysis andmaintained
on a C57Bl/6J background. All animals were cared for at the Cancer Research
UK Cambridge Institute Biological Resources Unit according to Home Office
regulations.
Whole-Mount Staining and Clone Scoring
Detection of SYNbglA expression was carried out as previously described
(Lopez-Garcia et al., 2010; McCutcheon et al., 2010).
Image Analysis
Tessellate photographs of R26[CA]30SYNbglA/Apcmin whole mounts were taken
on a dissecting microscope (Wild Heerbrugg M8) with additional incidental
lighting. Images were digitally stitched together to create a single image file
of each whole mount. This image was computationally analyzed (Supple-
mental Experimental Procedures) for detection of the tissue, pins, clones,
and adenomas. Subsequently, the area of individual clones and adenomas
was quantified in relation to a known size marker. This size in metric units
was then translated to a size in glands. To calculate the average size of a gland
within an Apcmin adenoma, hematoxylin and eosin-stained en face paraffin
sections were taken from ten adenomas. The tissue sections were then photo-
graphed (Leica DMI6000 B), and the sizes of 903 glands were quantified in
ImageJ (http://rsbweb.nih.gov/ij/).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.stem.2013.08.001.
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